Resultados de la búsqueda 171-180 of 9330 for Low-Dose Naltrexone
The purpose of this study is to do data collection of EEG findings to determine whether new types analysis of intracranial EEG can add different and ...
This study includes 2 parts; step-up dose optimization (Part 1) and dose expansion (Part 2). ... Small Cell Lung Cancer. Jacksonville, Fla. This ... small cell lung ...
Reduced Dose Hypofractionated Radiotherapy For Indolent Non-hodgkin Lymphoma. Rochester, Minn., La Crosse, Wis., Mankato, Minn., Eau Claire, Wis ...
This study includes 2 parts; step-up dose optimization (Part 1) and dose expansion (Part 2). ... In Part 2, the step-up dose ... low incomes or poor access to ...
Rochester, Minn. The overall objective of this study is to define genes causing cystic kidney disease and to determine the degree to which variants at these ...
The purpose of this study is to assess the differences in microvascular anastomosis outcomes between the experiment aneurysmal subarachnoid hemorrhage (aSAH)- ...
The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose ... low incomes or ...
Rochester, Minn. The purpose of this study is to assess the differences in microvascular anastomosis outcomes between the experiment aneurysmal subarachnoid ...
Durvalumab is FDA approved for treatment in lung cancers including non-small cell lung cancer and small cell lung cancer. ... Giving high dose chemotherapy ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?